TY - JOUR
T1 - A mimic of viral double-stranded RNA triggers fulminant type 1 diabetes-like syndrome in regulatory T cell-deficient autoimmune diabetic mouse
AU - Tada, Ai
AU - Shimada, Akira
AU - Yamada, Taketo
AU - Oikawa, Yoichi
AU - Yamada, Yoshifumi
AU - Okubo, Yoshiaki
AU - Irie, Junichiro
AU - Bluestone, Jeffrey A.
AU - Itoh, Hiroshi
N1 - Copyright:
Copyright 2012 Elsevier B.V., All rights reserved.
PY - 2011/11/15
Y1 - 2011/11/15
N2 - Human fulminant type 1 diabetes (FT1D) is an extremely aggressive disease. The delay of proper diagnosis results in high mortality. However, the pathophysiology of this disease remains unclear. We took advantage of CD28-deficient NOD (CD28 -/- NOD) mice, which have limited numbers of regulatory T cells and develop aggressive autoimmune diabetes, to create a FT1D model that mimicked the disease in humans. Young CD28 -/- NOD mice were injected with polyinosinic-polycytidylic acid to activate innate immunity in an effort to induce diabetes onset. In this model, innate immune cell activation precedes the onset of diabetes similar to ∼70% of FT1D patients. Eighty-three percent of CD28 -/- NOD mice developed diabetes within 1-6 d after injection of polyinosinic-polycytidylic acid. Moreover, T cells infiltrated the pancreatic exocrine tissue and destroyed a cells, an observation characteristic of human FT1D. We conclude that an FT1D-like phenotype can be induced in the background of autoimmune diabetes by a mimic of viral dsRNA, and this model is useful for understanding human FT1D.
AB - Human fulminant type 1 diabetes (FT1D) is an extremely aggressive disease. The delay of proper diagnosis results in high mortality. However, the pathophysiology of this disease remains unclear. We took advantage of CD28-deficient NOD (CD28 -/- NOD) mice, which have limited numbers of regulatory T cells and develop aggressive autoimmune diabetes, to create a FT1D model that mimicked the disease in humans. Young CD28 -/- NOD mice were injected with polyinosinic-polycytidylic acid to activate innate immunity in an effort to induce diabetes onset. In this model, innate immune cell activation precedes the onset of diabetes similar to ∼70% of FT1D patients. Eighty-three percent of CD28 -/- NOD mice developed diabetes within 1-6 d after injection of polyinosinic-polycytidylic acid. Moreover, T cells infiltrated the pancreatic exocrine tissue and destroyed a cells, an observation characteristic of human FT1D. We conclude that an FT1D-like phenotype can be induced in the background of autoimmune diabetes by a mimic of viral dsRNA, and this model is useful for understanding human FT1D.
UR - http://www.scopus.com/inward/record.url?scp=81455131879&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=81455131879&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1000837
DO - 10.4049/jimmunol.1000837
M3 - Article
C2 - 21967896
AN - SCOPUS:81455131879
SN - 0022-1767
VL - 187
SP - 4947
EP - 4953
JO - Journal of Immunology
JF - Journal of Immunology
IS - 10
ER -